Biomedical Textiles Market Research Report Information By Fiber Type (Non-Biodegradable, Biodegradable), Fabric Type (Woven, Non-Woven), Product Type (Non-Implantable, Implantable), Applications (Dentistry, General Surgery & Treatment), Region – Forecast Till 2030

Biomedical Textiles Market Overview

 The biomedical textiles market is estimated to be USD 10.101 billion in 2021 and is projected to reach USD 14.58 billion by 2030, at a CAGR of 5.9% between 2021 and 2030. Biomedical textiles are fabrics that have been specifically created for use in biological conditions. The biocompatibility of these fabrics with biological cells, tissue, and fluids determines their performance. They are part of the medical textiles branch of the technical textiles department. Non-toxic, non-carcinogenic, non-allergic biomedical textiles should be sterilized, chemically inert, biocompatible, high strength, flexible, and have outstanding durability. End-use applications for biomedical textiles include ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery and therapy, and others. Healthcare and hygiene items, non-implantable products, implantable products, and extracorporeal devices are all examples of biomedical textiles in use. Surgical garments, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and other healthcare and hygiene goods are used to protect healthcare staff and patients from contamination by blood and other infectious fluids. Non-implantable goods are used to provide protection against infection, absorption and exudation of blood and excess fluids, and healing applications through external application to the body with or without skin contact. Over the projected period, the global biomedical textiles market is expected to be driven by expanding healthcare budgets, rising health awareness, and rising healthcare expenditure.

Key Players

Some of the prominent players in the global biomedical textiles market are Secant Group, LLC (U.S.), Confluent Medical Technologies (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).

Global Biomedical Textiles Market Share in 2017, by Product Type

 

Source: MRFR Analysis

Market Segmentation

The global biomedical textiles market is segmented by fiber type, fabric type, product type, application, and region.

On the basis of the fiber type, the global biomedical textiles market is segmented into the non-biodegradable fiber and biodegradable fiber.  Non-biodegradable fiber is sub-segmented into polypropylene, polyethylene, polyester, polyamide, polyurethane, polytetrafluoroethylene, and others. Biodegradable fiber is sub-segmented into cotton, viscose rayon, collagen, chitin, and others.

On the basis of the fabric type, the global biomedical textiles market is segmented into woven, non-woven, knitted & braided fabrics, hollow fabric, and others.

On the basis of the product type, the global biomedical textiles market is segmented into healthcare & hygiene products, non-implantable products, implantable products, and extracorporeal devices. Healthcare & hygiene products are sub-segmented into surgical clothing, surgical drapes, beddings, sanitary napkins, baby diapers, adult incontinence products, and others. Non-implantable products are sub-segmented into bandages, wound care dressings, plasters, gauze, and others. Implantable products are sub-segmented into soft tissue implants (hernia repair, ligament implant), hard tissue implants (orthopedic implant, dental implant), cardiovascular implants (vascular graft, heart valve), surgical sutures, and others. Extracorporeal devices are sub-segmented into artificial kidney, liver, and lungs.

Based on applications, the global biomedical textiles market is segmented into ophthalmology, neurology, cardiology, dentistry, orthopedics, general surgery & treatment, and others.

Regional Analysis

The global biomedical textiles market is segmented into five regions namely Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa. 

Asia Pacific was a lucrative market for biomedical textiles in 2017 and is expected to witness a considerable demand during the forecast period. A large population base in Asia Pacific drives the strong need for healthcare facilities to combat cases of the aging population, rising cases of chronic & lifestyle diseases, accident cases; this is likely to boost demand of biomedical textiles in healthcare industry during the forecast period. Additionally, growing foreign investments in healthcare sector due to relaxed investments norms as well as various government initiatives such as high budget allocation for healthcare sector is likely to impact the healthcare industry positively and thus are expected to surge the demand for biomedical textiles over the forecast period.

North America and Europe market are relatively mature and are expected to witness steady demand for biomedical textiles owing to the limited growth scope during the forecast period.

The Middle East & Africa is expected to witness rising demand for biomedical textiles mostly from GCC countries owing to their growing healthcare expanding projects to strengthen the industry during the forecast period.

Latin America is expected to witness a moderate growth over the forecast period. Brazil healthcare industry is expected to drive the largest demand for biomedical textiles, followed by a demand from Mexico, Chile, Peru, and Columbia country.Recent Development

In November 2017, DSM Biomedical collaborated with Meister & Cie AG to develop a new braiding method. UHMWPE fibers, specifically Dyneema Purity fibers, are used in the design and fabrication of implantable medical devices. This platform technology gives medical device producers design freedom and the ability to miniaturize devices, allowing biomedical textiles to be used in more applications. The new SynchroMed(TM) II Intrathecal Medicine Delivery system, an implanted pump that delivers tailored drug delivery for chronic pain and severe spasticity, was released by Medtronic plc in January 2018. The SynchroMed II pump administers medication directly to the spinal fluid. A small number of prominent businesses control a significant percentage of the market.

Intended Audience

• Biomedical textiles manufacturers


• Traders and distributors of biomedical textiles


• Research and development institutes


• Potential investors


• Raw material suppliers


• Nationalized laboratory

Report Attribute/Metric	Details
Market Size	2030: 14.58 billion
CAGR	5.9% (2021-2030)
Base Year	2021
Forecast Period	2021 to 2030
Historical Data	2019 & 2020
Forecast Units	Value (USD Million)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	fiber type, fabric type, product type and application
Geographies Covered	Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa.
Key Vendors	Secant Group, LLC (U.S.), Confluent Medical Technologies (U.S.), SWICOFIL AG (Switzerland), Johnson & Johnson Services, Inc. (U.S.), Meister & Cie AG (Switzerland), Cardinal Health. (U.S.), Smith & Nephew (UK), Medline Industries, Inc (India), Integra LifeSciences Corporation. (U.S.), PAUL HARTMANN AG (Germany), BSN medical. (Germany), B. Braun Melsungen AG (Germany), 3M (U.S.), Elkem Silicones (Norway), and ATEX TECHNOLOGIES (U.S.).
Key Market Opportunities	Huge market scope for biomedical textiles in the healthcare industry
Key Market Drivers	Growing healthcare industry on account of rising healthcare budget, growing health awareness, and rising healthcare expenditure is likely to drive the global biomedical textiles industry